4
Changes in Ownership
Sarepta Therapeutics, Inc. Filed Acc 0000950170-25-036694
Head of R&D, CSO gave up 8,504 shares (to pay taxes)
- Head of R&D, CSO acquired 17,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Rodino-Klapac Louise · Head of R&D, CSO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-06 | Exercise or conversion : show line 1 in the form | +17,500 | 82,822 | D | ||
| 2025-03-07 | Shares withheld for taxes : show line 2 in the form | −514 | $103.70 | $53,302 | 82,308 | D |
| 2025-03-07 | Shares withheld for taxes : show line 3 in the form | −7,990 | $103.70 | $828,563 | 74,318 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-03-06 | Exercise or conversion : show line 4 in the form Performance Stock Units | −17,500 | 0 | D |
Loading xslF345X05/ownership.xml…